These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 26558489)

  • 21. Fingerprint design and engineering strategies: rationalizing and improving similarity search performance.
    Heikamp K; Bajorat J
    Future Med Chem; 2012 Oct; 4(15):1945-59. PubMed ID: 23088275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacophore-based virtual screening.
    Horvath D
    Methods Mol Biol; 2011; 672():261-98. PubMed ID: 20838973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular fingerprint similarity search in virtual screening.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Garcia-Vallvé S; Pujadas G
    Methods; 2015 Jan; 71():58-63. PubMed ID: 25132639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigating Pharmacological Similarity by Charting Chemical Space.
    Buonfiglio R; Engkvist O; Várkonyi P; Henz A; Vikeved E; Backlund A; Kogej T
    J Chem Inf Model; 2015 Nov; 55(11):2375-90. PubMed ID: 26484706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electron density fingerprints (EDprints): virtual screening using assembled information of electron density.
    Kooistra AJ; Binsl TW; van Beek JH; de Graaf C; Heringa J
    J Chem Inf Model; 2010 Oct; 50(10):1772-80. PubMed ID: 20839826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similarity-based virtual screening using 2D fingerprints.
    Willett P
    Drug Discov Today; 2006 Dec; 11(23-24):1046-53. PubMed ID: 17129822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a fingerprint reduction approach for Bayesian similarity searching based on Kullback-Leibler divergence analysis.
    Nisius B; Vogt M; Bajorath J
    J Chem Inf Model; 2009 Jun; 49(6):1347-58. PubMed ID: 19480403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reverse fingerprinting, similarity searching by group fusion and fingerprint bit importance.
    Williams C
    Mol Divers; 2006 Aug; 10(3):311-32. PubMed ID: 17031535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo design - hop(p)ing against hope.
    Schneider G
    Drug Discov Today Technol; 2013 Dec; 10(4):e453-60. PubMed ID: 24451634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circular fingerprints: flexible molecular descriptors with applications from physical chemistry to ADME.
    Glem RC; Bender A; Arnby CH; Carlsson L; Boyer S; Smith J
    IDrugs; 2006 Mar; 9(3):199-204. PubMed ID: 16523386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergies of virtual screening approaches.
    Muegge I
    Mini Rev Med Chem; 2008 Aug; 8(9):927-33. PubMed ID: 18691150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A knowledge-based weighting approach to ligand-based virtual screening.
    Stiefl N; Zaliani A
    J Chem Inf Model; 2006; 46(2):587-96. PubMed ID: 16562987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How diverse are diversity assessment methods? A comparative analysis and benchmarking of molecular descriptor space.
    Koutsoukas A; Paricharak S; Galloway WR; Spring DR; Ijzerman AP; Glen RC; Marcus D; Bender A
    J Chem Inf Model; 2014 Jan; 54(1):230-42. PubMed ID: 24289493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.